News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
FDA Approves Purdue Pharma L.P.'s New Opioid-Based Pain Medicine
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
The U.S. Food and Drug Administration on Friday approved a new Purdue Pharma L.P. opioid-based drug that aims to provide "around-the-clock" relief to patients with moderate to severe pain.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Lung cancer
Bayer Wins Lung Cancer Accelerated Approval for Kinase Inhibitor
November 20, 2025
·
1 min read
·
Tristan Manalac
Approvals
FDA Hands Regeneron Two Eylea HD Nods in One Day
November 20, 2025
·
2 min read
·
Tristan Manalac
Drug Development
CRO Boom in APAC region, With China at the Forefront
November 19, 2025
·
5 min read
·
Jennifer Smith-Parker
FDA
Makary Eyes ‘America-First’ User Fee Structure as Renewal Negotiations Approach
November 19, 2025
·
2 min read
·
Tristan Manalac